Jatenzo Cost in Connecticut 2026: Cash Price, Insurance, and Savings Options

What Is the Actual Cash Price of Jatenzo in Connecticut?

The retail cash price for Jatenzo in Connecticut is approximately $900 per month for a 60-capsule supply (237 mg twice daily). That figure represents the manufacturer's list price set by Tolmar Pharmaceuticals and is consistent across major Connecticut retail chains such as CVS, Walgreens, and independent compounding pharmacies that carry the brand. Without insurance or a savings program, most patients pay close to this amount.

Jatenzo (oral testosterone undecanoate) received FDA approval in March 2019 under NDA 210842 for adult males with hypogonadism caused by certain medical conditions. The FDA label specifies the starting dose at 237 mg twice daily with food, with titration based on morning serum testosterone drawn 3 to 5 hours after the dose. [1]

The key pharmacokinetic trial by Swerdloff et al. (J Clin Endocrinol Metab, 2020, N=166) showed that 87% of treated men achieved average testosterone concentrations within the normal range (300 to 1 to 000 ng/dL) at the 237 mg twice-daily dose, with a mean Cavg of 498 ng/dL. [2] That efficacy profile supports its positioning as a first oral testosterone approved in the United States since methyltestosterone, but the cost structure means access depends heavily on insurance coverage.

Prices at individual Connecticut pharmacies may differ by $30 to $60 depending on local dispensing fees. Checking GoodRx or calling the pharmacy directly with the NDC number (NDC 70408-314-60) can reveal whether any negotiated cash price applies.

Does Connecticut Medicaid Cover Jatenzo?

Connecticut Medicaid (HUSKY Health) covers Jatenzo, but prior authorization is required before the pharmacy will dispense it. The PA process typically asks the prescriber to document a confirmed diagnosis of hypogonadism (serum testosterone <300 ng/dL on two morning draws), a reason why injectable or topical testosterone formulations are medically inappropriate, and the absence of contraindications such as prostate cancer or a hematocrit above 54%. [3]

PA approval timelines through the Connecticut DSS Pharmacy Unit run 3 to 5 business days for standard requests and 24 hours for urgent requests. Denials can be appealed, and physicians at HealthRX routinely include the Swerdloff et al. 2020 clinical data in appeal letters to demonstrate that oral delivery produces equivalent testosterone normalization to injectable cypionate in patients with documented adherence issues. [2]

Once approved, Connecticut Medicaid patients generally pay the standard Medicaid co-pay tier, which in 2026 is $3 for preferred brand medications. That makes Medicaid the lowest-cost access pathway for eligible residents. Patients enrolled in a Connecticut Medicaid Managed Care Organization (MCO) such as Aetna Better Health CT or Anthem HealthKeepers CT should verify the drug's tier status directly with their MCO, since formulary placement may differ from the fee-for-service HUSKY list.

The American Urological Association's 2018 guideline on testosterone deficiency states that "testosterone therapy is indicated in symptomatic men with consistently low testosterone levels and no contraindications." [4] Medicaid PA reviewers cite that standard when evaluating clinical necessity for oral formulations specifically.

Which Connecticut Commercial Insurance Plans Cover Jatenzo?

Most large commercial insurers operating in Connecticut place Jatenzo on a non-preferred brand tier (Tier 3 or Tier 4), which translates to a co-pay ranging from $75 to $200 per month after the deductible is met. [5] Plans from Anthem BCBS CT, ConnectiCare, Harvard Pilgrim, and Cigna all listed Jatenzo as covered with step therapy as of Q1 2026.

Step therapy requirements are the biggest barrier. Virtually every Connecticut commercial plan requires that patients first try and fail at least one generic testosterone alternative, typically testosterone cypionate injection or a generic topical gel (testosterone 1.62% gel), before the plan will cover Jatenzo. The step requirement exists because generic testosterone cypionate costs insurers roughly $30 to $60 per month versus $900 for Jatenzo. [6]

Connecticut passed step therapy reform legislation (Public Act 17-172) that allows physicians to request a step therapy exception when a required therapy is contraindicated, previously tried and failed, or would cause an adverse drug reaction. A prescriber's clinical note documenting, for example, that a patient cannot reliably self-administer injections or has a documented skin reaction to topical gel satisfies the exception criteria in most cases.

The Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy recommends using "formulations and delivery systems that maintain physiological testosterone levels and that have the fewest side effects and the most convenience for the patient." [7] That language supports exceptions for patients with documented compliance problems tied to route of administration.

How Does the Tolmar Savings Card Work in Connecticut?

The Tolmar Jatenzo savings card is available to commercially insured patients who are not enrolled in any federal or state government insurance program, including Medicare, Medicaid, TRICARE, or VA benefits. Eligible patients in Connecticut can enroll at the Tolmar patient support portal and receive a co-pay card that covers out-of-pocket costs, potentially bringing the monthly cost to $0 for qualifying patients. [8]

Practically, the card functions as a secondary payer. The pharmacy runs the patient's primary insurance first, then runs the savings card to cover the remaining co-pay, coinsurance, or deductible amount up to the program maximum. Tolmar's 2026 program maximum is $2,400 per calendar year, equivalent to $200 per month if spread evenly. [8]

Key eligibility requirements to confirm before presenting at a Connecticut pharmacy:

• Must be commercially insured (employer plan, marketplace plan, or private plan)
• Cannot be a government program beneficiary
• Must be a resident of the United States (Connecticut qualifies)
• Card is valid for 12 months from enrollment date

Patients whose plans have a high-deductible structure should request a 30-day supply first to confirm the card processes correctly before the 90-day fill is attempted. Some Connecticut pharmacy systems have flagged savings card rejections when the deductible accumulator adjudication resets mid-year.

What Is the Cheapest Way to Get Jatenzo in Connecticut?

For commercially insured patients, stacking the Tolmar savings card on top of a plan with even a Tier 3 co-pay is often the least expensive path, since the card can reduce the net cost to near $0. For uninsured or underinsured patients, two lower-cost options exist. [9]

Connecticut Medicaid (HUSKY Health). If a patient meets income and medical eligibility, the $3 Medicaid co-pay after PA approval is the most affordable route to branded Jatenzo.

Compounded oral testosterone undecanoate from a 503A pharmacy. Connecticut law permits licensed 503A compounding pharmacies to prepare oral testosterone undecanoate capsules for individual patients with a valid prescription. Compounded TU is not bioequivalent to FDA-approved Jatenzo and has not undergone the same rigorous NDA stability and bioavailability testing. Costs at Connecticut compounding pharmacies in 2026 range from $0 (for patients with certain coverage arrangements) to approximately $80 per month for cash-pay patients.

A March 2023 FDA guidance document clarifies that compounded testosterone products are not FDA-approved and that patients and prescribers assume responsibility for formulation variability. [10] HealthRX physicians who prescribe compounded oral TU in Connecticut document this discussion in the medical record and monitor serum testosterone levels at weeks 4, 8, and 12 to confirm adequate absorption.

Patient Assistance Programs. Tolmar's financial assistance program, separate from the co-pay card, provides Jatenzo at no cost to uninsured patients meeting income thresholds below 400% of the federal poverty level. The 2026 income cutoff for a single-person Connecticut household is approximately $60,240. Applications go through Tolmar's medical affairs team and take 10 to 14 business days. [8]

Is Compounded Oral Testosterone Undecanoate Legal in Connecticut?

Yes. Compounding by a licensed 503A pharmacy in Connecticut is legal when a licensed prescriber issues a patient-specific prescription and the preparation does not replicate a commercially available product in a way that FDA determines creates a safety concern. [11] Oral testosterone undecanoate sits in a regulatory gray zone because Jatenzo is an FDA-approved brand, which means 503A pharmacies must document patient-specific clinical necessity for the compounded version rather than simply substituting it for the brand.

Connecticut's Department of Consumer Protection, Pharmacy Unit, licenses and inspects 503A compounding pharmacies operating in the state. A compounding pharmacy in Connecticut may not prepare large batches of oral testosterone undecanoate for office stock or for resale without 503B outsourcing facility registration with the FDA. Patients ordering compounded oral TU online from out-of-state pharmacies should verify that the pharmacy holds a valid Connecticut non-resident pharmacy permit before accepting the prescription. [12]

The clinical difference between compounded and branded oral TU matters. The Swerdloff et al. 2020 trial, which underpinned FDA approval for Jatenzo, used a specific self-emulsifying drug delivery system (SEDDS) formulation to achieve predictable lymphatic absorption. [2] Compounded capsules that use different excipients may produce different testosterone exposure curves, which is why therapeutic drug monitoring at 3 to 5 hours post-dose is recommended regardless of which formulation the patient uses. [1]

Can Telehealth Providers Prescribe Jatenzo in Connecticut?

Telehealth prescribing of Jatenzo is permitted in Connecticut. The state follows the Ryan Haight Online Pharmacy Consumer Protection Act framework, which requires a valid prescriber-patient relationship and, for controlled substances, either an in-person evaluation or a DEA-authorized telemedicine platform. Testosterone is a Schedule III controlled substance under the federal Controlled Substances Act and under Connecticut General Statutes Section 21a-243.

That Schedule III status means Connecticut telehealth prescribers must hold an active DEA registration, must verify the patient's identity, must review serum testosterone laboratory results, and must document symptom criteria consistent with hypogonadism before issuing a Jatenzo prescription. [13] Platforms that conduct only a questionnaire-based "low T" assessment without laboratory confirmation do not meet the Connecticut standard of care for testosterone prescribing.

A standard HealthRX telehealth evaluation for Jatenzo in Connecticut includes two morning (7 a.m. to 10 a.m.) serum total testosterone draws on separate days, a complete metabolic panel, a lipid panel, hematocrit, PSA (for men over 40), and a brief clinical history assessing libido, energy, mood, and body composition. Results are reviewed by a Connecticut-licensed physician or APRN prior to prescribing.

After initiation, the FDA label mandates a blood pressure measurement at 6 weeks because Jatenzo modestly raises blood pressure in clinical trials (mean increase of 3.5 mmHg systolic in the Swerdloff trial). [1][2] Telehealth follow-up at week 6 accommodates that monitoring requirement.

How Does Jatenzo Compare to Injectable and Topical Testosterone on Cost in Connecticut?

The cost differential between Jatenzo and other testosterone formulations is large. Generic testosterone cypionate 200 mg/mL (10 mL vial) retails for $30 to $60 per month at Connecticut pharmacies. Generic testosterone 1.62% gel (a 75 g pump) costs $40 to $90 per month. Testosterone pellets implanted subcutaneously every 3 to 6 months cost $300 to $600 per procedure at Connecticut urology and men's health practices. [6]

Jatenzo's $900 list price is 10 to 30 times higher than injectable cypionate. The trade-off is convenience: no injections, no transference risk to partners or children from skin contact, and no clinic visits for pellet insertion. For patients who cannot or will not use other formulations, that convenience premium may be clinically justified.

The FDA approval label for Jatenzo notes a contraindication in men with severe hepatic impairment, a warning for blood pressure elevation, and a warning regarding polycythemia. [1] Those considerations do not alter the cost calculus but do affect which patients are appropriate candidates, and they should be reviewed with the prescribing clinician before choosing Jatenzo over a lower-cost alternative.

Nasal testosterone gel (Natesto, 4.5 mg per actuation) and subcutaneous testosterone enanthate auto-injector (Xyosted) fall in the $400 to $600 per month range and may represent a middle ground for patients who want to avoid traditional injections but cannot absorb the full Jatenzo cost. [9]

Monitoring Requirements That Affect Ongoing Cost in Connecticut

Beyond the drug cost itself, ongoing laboratory monitoring adds to the total annual cost of Jatenzo therapy. The Endocrine Society guideline recommends serum testosterone at 3 months after initiation, then annually; hematocrit at 3 months, then annually; PSA at 3 and 12 months in men over 40; and blood pressure monitoring at 6 weeks and 6 months. [7]

In Connecticut, a standard testosterone panel (total T, free T, SHBG, LH, FSH, hematocrit, PSA) costs between $80 and $200 at outpatient lab draw stations depending on whether the patient uses LabCorp, Quest, or a hospital-affiliated lab. Insurance coverage for monitoring labs varies by plan but is generally covered under the chronic disease management benefit once hypogonadism is coded on the claim.

The 6-week blood pressure check required by the Jatenzo label can be completed via a telehealth visit with a Bluetooth blood pressure cuff, eliminating an in-person clinic visit. That approach keeps the 6-week touchpoint cost to roughly $0 to $30 in Connecticut, depending on the telehealth platform's visit fee structure. [1]